chr13-59666695-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001042517.2(DIAPH3):c.3471G>A(p.Ala1157Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0518 in 1,614,044 control chromosomes in the GnomAD database, including 2,270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.051 ( 213 hom., cov: 33)
Exomes 𝑓: 0.052 ( 2057 hom. )
Consequence
DIAPH3
NM_001042517.2 synonymous
NM_001042517.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.15
Genes affected
DIAPH3 (HGNC:15480): (diaphanous related formin 3) This gene encodes a member of the diaphanous subfamily of the formin family. Members of this family are involved in actin remodeling and regulate cell movement and adhesion. Mutations in this gene are associated with autosomal dominant auditory neuropathy 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 13-59666695-C-T is Benign according to our data. Variant chr13-59666695-C-T is described in ClinVar as [Benign]. Clinvar id is 517828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-59666695-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0527 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIAPH3 | NM_001042517.2 | c.3471G>A | p.Ala1157Ala | synonymous_variant | 28/28 | ENST00000400324.9 | NP_001035982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIAPH3 | ENST00000400324.9 | c.3471G>A | p.Ala1157Ala | synonymous_variant | 28/28 | 1 | NM_001042517.2 | ENSP00000383178.3 | ||
DIAPH3 | ENST00000400319.5 | c.3261G>A | p.Ala1087Ala | synonymous_variant | 26/26 | 1 | ENSP00000383173.1 |
Frequencies
GnomAD3 genomes AF: 0.0507 AC: 7716AN: 152102Hom.: 213 Cov.: 33
GnomAD3 genomes
AF:
AC:
7716
AN:
152102
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0471 AC: 11750AN: 249440Hom.: 311 AF XY: 0.0472 AC XY: 6387AN XY: 135312
GnomAD3 exomes
AF:
AC:
11750
AN:
249440
Hom.:
AF XY:
AC XY:
6387
AN XY:
135312
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0520 AC: 75969AN: 1461824Hom.: 2057 Cov.: 31 AF XY: 0.0518 AC XY: 37635AN XY: 727208
GnomAD4 exome
AF:
AC:
75969
AN:
1461824
Hom.:
Cov.:
31
AF XY:
AC XY:
37635
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0507 AC: 7713AN: 152220Hom.: 213 Cov.: 33 AF XY: 0.0499 AC XY: 3715AN XY: 74420
GnomAD4 genome
AF:
AC:
7713
AN:
152220
Hom.:
Cov.:
33
AF XY:
AC XY:
3715
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
131
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 26, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at